Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method.
Dou, Y., Xu, K., Deng, Y.Q., Jia, Z., Lan, J., Xu, X., Zhang, G., Cao, T., Liu, P., Wang, X., Wang, X., Xu, L., Du, P., Qin, C.F., Liu, H., Li, Y., Wu, G., Wang, K., Lu, B.(2023) Antib Ther 6: 76-86
- PubMed: 37077472 
- DOI: https://doi.org/10.1093/abt/tbad002
- Primary Citation of Related Structures:  
7F3Q - PubMed Abstract: 
Rapid and efficient strategies are needed to discover neutralizing antibodies (nAbs) from B cells derived from virus-infected patients.
Organizational Affiliation: 
School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing 100084, China.